Monday, April 29, 2013

Bioinformatics Technologies and Global Markets

BCC Research’s goal for this study is to provide a comprehensive analysis of the bioinformatic market by reviewing the recent advances in high-throughput ‘omic technologies and computer-enabled technologies that have driven the field forward. It examines the market trends and analysis regarding industry service providers, software solution developers, and IT and bioinformatics service providers that support the pharma industry.
Since the Human Genome Project was completed in April 2003, genome-wide association studies (GWAS) have contributed toward a greater understanding of the genetic basis of complex diseases and advances in high-throughput technologies. This has enabled researchers to rapidly map the genome of vertebrates, invertebrates and pathogens through cost-effective methods.More recently, improvements in cloud computing capabilities and advances in data-analysis software services have helped to expand the evaluation of available datasets, allowing researchers to build systems biology models of various diseases. Still, the challenge to translate this wealth of information into tangible clinical benefits, to support the development of new therapeutic interventions and to reduce the current prohibitively high cost of drug development remains.
 To Know More - Bioinformatics Technologies and Global Markets

No comments:

Post a Comment